Get the app
USBasic Materials

BioNexus Gene Lab Corp Common stock (BGLC)

US · Basic Materials · Specialty Chemicals

$1.48-0.34%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$76,156
Revenue YoY
-96.6%
Net profit
$-286,451
EPS
$-0.12
Net margin
-376.1%

Key statistics

Market cap
$4.7M
Forward P/E
0.0
P/B
0.61
Book value
$3.22
EPS (TTM)
$-1.26
52-week high
$6.10
52-week low
$1.07
50-day MA
$1.58
200-day MA
$2.46
Beta
2.21

Shareholding

Insiders
44.72%
Institutions
0.49%

Largest institutional holders

FundStake
UBS Group AG0.01%
Wells Fargo & Co0.00%
DRW Securities, LLC0.00%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for BioNexus Gene Lab Corp Common stock — free to start.

Google PlayApp Store

Other Basic Materials companies

Data updated 2026-09-18.